Open AccessSodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials
Author(s) -
Neelam Mittal,
Ravi Mittal,
Harish Kumar,
Bikash Medhi
Publication year - 2016
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.173777
Subject(s) - jadad scale , medicine , randomized controlled trial , glycemic , consolidated standards of reporting trials , blinding , generalizability theory , cohen's kappa , clinical trial , research design , family medicine , psychology , statistics , insulin , developmental psychology , mathematics , cochrane library
Sodium glucose co-transporter 2 inhibitors represent a novel class of antidiabetic drugs. The reporting quality of the trials evaluating the efficacy of these agents for glycemic control in type 2 diabetes mellitus has not been explored. Our aim was to assess the reporting quality of such randomized controlled trials (RCTs) and to identify the predictors of reporting quality.